Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2009 by Rajavithi Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Rajavithi Hospital
ClinicalTrials.gov Identifier:
NCT01546376
First received: March 2, 2012
Last updated: March 6, 2012
Last verified: January 2009

March 2, 2012
March 6, 2012
August 2009
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT01546376 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients
Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients

Objectives: To study immunostatus (CD4) and HIV viral load in HIV-cancer patients before RT and last weeks of RT .

Not Provided
Observational
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

HIV positive cancer patients Curative RT treatment

  • To Study Immunostatus of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT
  • To Study HIV Viral Load of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT
  • Radiation: Radiation therapy
    External photon beam radiation therapy dosage 4000-7000 CGy
  • Other: Venepuncture
    Venepuncture for CD4 and viral load count at Week 0, Last week of Radiation, and 12, 24 Week follow up
HIV-cancer patients who recived RT
Interventions:
  • Radiation: Radiation therapy
  • Other: Venepuncture
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
100
Not Provided
Not Provided

Inclusion Criteria:

  • Age 18-65 years
  • HIV positive cancer patients
  • Photon beam RT, conventional fraction >= 4000 cgy in 4 weeks

Exclusion Criteria:

  • CD4 count < 200 cell/ml and not received anti retro viral
Both
18 Years to 65 Years
Yes
Contact: Pathomphorn Siraprapasiri, MD 66-89-6662960 spathomphorm@gmail.com
Thailand
 
NCT01546376
THAIHIV001
No
Rajavithi Hospital
Rajavithi Hospital
Not Provided
Not Provided
Rajavithi Hospital
January 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP